These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29228743)

  • 1. Prognostic role of DEK in human solid tumors: a meta-analysis.
    Liu G; Xiong D; Zeng J; Xu G; Xiao R; Chen B; Huang Z
    Oncotarget; 2017 Nov; 8(58):98985-98992. PubMed ID: 29228743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
    Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G
    PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of HOXA13 in solid tumors: A meta-analysis.
    Wen Y; Shu F; Chen Y; Chen Y; Lan Y; Duan X; Zhao SC; Zeng G
    Clin Chim Acta; 2018 Aug; 483():64-68. PubMed ID: 29678634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of B7-H3 expression in patients with solid tumors: a meta-analysis.
    Zhang X; Fang C; Zhang G; Jiang F; Wang L; Hou J
    Oncotarget; 2017 Nov; 8(54):93156-93167. PubMed ID: 29190985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetraspanin CD151 as an emerging potential poor prognostic factor across solid tumors: a systematic review and meta-analysis.
    Zeng P; Wang YH; Si M; Gu JH; Li P; Lu PH; Chen MB
    Oncotarget; 2017 Jan; 8(3):5592-5602. PubMed ID: 27888619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of ZEB-1 in solid tumors: a meta-analysis.
    Chen B; Chen B; Zhu Z; Ye W; Zeng J; Liu G; Wang S; Gao J; Xu G; Huang Z
    BMC Cancer; 2019 Jun; 19(1):635. PubMed ID: 31248382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poor prognosis of nucleophosmin overexpression in solid tumors: a meta-analysis.
    Chen S; He H; Wang Y; Liu L; Liu Y; You H; Dong Y; Lyu J
    BMC Cancer; 2018 Aug; 18(1):838. PubMed ID: 30126359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Prognostic Value of Decreased LKB1 in Solid Tumors: A Meta-Analysis.
    Xiao J; Zou Y; Chen X; Gao Y; Xie M; Lu X; Li W; He B; He S; You S; Chen Q
    PLoS One; 2016; 11(4):e0152674. PubMed ID: 27035914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APE1 overexpression is associated with poor survival in patients with solid tumors: a meta-analysis.
    Yuan CL; He F; Ye JZ; Wu HN; Zhang JY; Liu ZH; Li YQ; Luo XL; Lin Y; Liang R
    Oncotarget; 2017 Aug; 8(35):59720-59728. PubMed ID: 28938675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poor prognosis and SATB1 overexpression in solid tumors: a meta-analysis.
    Wang S; Zeng J; Xiao R; Xu G; Liu G; Xiong D; Ye Y; Chen B; Wang H; Luo Q; Huang Z
    Cancer Manag Res; 2018; 10():1471-1478. PubMed ID: 29922091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PBK/TOPK overexpression and survival in solid tumors: A PRISMA-compliant meta-analysis.
    Xu M; Xu S
    Medicine (Baltimore); 2019 Mar; 98(10):e14766. PubMed ID: 30855480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of YKL-40 in solid tumors: a meta-analysis of 41 cohort studies.
    Bian B; Li L; Yang J; Liu Y; Xie G; Zheng Y; Zeng L; Zeng J; Shen L
    Cancer Cell Int; 2019; 19():259. PubMed ID: 31624472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TMPRSS4 as an emerging potential poor prognostic factor for solid tumors: A systematic review and meta-analysis.
    Zeng P; Zhang P; Zhou LN; Tang M; Shen YX; Jin J; Zhu YQ; Chen MB
    Oncotarget; 2016 Nov; 7(46):76327-76336. PubMed ID: 27344186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of DcR3 in solid tumors: A meta-analysis.
    Ge H; Liang C; Ren S; Yue C; Wu J
    Clin Chim Acta; 2018 Jun; 481():126-131. PubMed ID: 29499202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of SOX2 overexpression in prognosis of patients with solid tumors: A meta-analysis and system review.
    Wang S; Liu X; Chen Y; Zhan X; Wu T; Chen B; Sun G; Yan S; Xu L
    Medicine (Baltimore); 2020 Mar; 99(13):e19604. PubMed ID: 32221082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDC20 overexpression leads to poor prognosis in solid tumors: A system review and meta-analysis.
    Wang S; Chen B; Zhu Z; Zhang L; Zeng J; Xu G; Liu G; Xiong D; Luo Q; Huang Z
    Medicine (Baltimore); 2018 Dec; 97(52):e13832. PubMed ID: 30593179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysis.
    Yang JJ; Hu ZG; Shi WX; Deng T; He SQ; Yuan SG
    World J Gastroenterol; 2015 Mar; 21(9):2807-15. PubMed ID: 25759553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of p62 in solid tumor patients: a meta-analysis.
    Ruan H; Xu J; Wang L; Zhao Z; Kong L; Lan B; Li X
    Oncotarget; 2018 Jan; 9(3):4258-4266. PubMed ID: 29423120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognositic value of CD73-adenosinergic pathway in solid tumor: A meta-analysis and systematic review.
    Wang R; Zhang Y; Lin X; Gao Y; Zhu Y
    Oncotarget; 2017 Aug; 8(34):57327-57336. PubMed ID: 28915673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyruvate kinase M2 overexpression and poor prognosis in solid tumors of digestive system: evidence from 16 cohort studies.
    Wu J; Hu L; Chen M; Cao W; Chen H; He T
    Onco Targets Ther; 2016; 9():4277-88. PubMed ID: 27478385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.